Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Older Versus Younger Patients.

Cancers (Basel) · 2025 · PMC11763395 · PMID 39858092

Europe PMC DOI

hedged sentence

0.1210

closest p · 2.4× alpha

0.1210

boldest claim

The sentences

showed a trendp = 0.121not close (p > 0.1)

Subgroup analysis of patients ≥60 years showed a trend toward improved 2-year OS with fludarabine/cyclophosphamide/total body irradiation (Flu/Cy/TBI) versus fludarabine/busulfan: 71% versus 53% (HR = 0.47, p = 0.121).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.